According to the CDC, the Human Papillomavirus (HPV) causes over 10,000 cancers per year in both men and women in the United States. Existing evidence suggests that HPV vaccination can prevent most of them. For that reason, the FDA and CDC both recommend vaccination before adolescence.
Gardasil (and Gardasil 9) is a vaccine used for the prevention of certain strains of HPV. As with many other vaccines, side effects are extremely rare, but they do exist. Adverse events which occur after a vaccine administration and are reported to health care professionals are recorded in the Vaccine Adverse Event Reporting System (VAERS). According to VAERS, the most common side effects are mild and include:
pain, redness, or swelling at the injection site,
headache or feeling tired,
muscle or joint pain.
However, other rare but more serious side effects can occur, as well. For that reason, the Vaccine Injury Compensation Program (VICP) exists. The VICP is a no-fault system which can provide compensation for people who have been injured by a vaccine administration.
Certain injuries occurring within a specified period after a vaccine administration are called, "table injuries." These generally do not require the claimant to provide evidence that the vaccine caused the injury – only that the injury occurred within the specified timeframe after the specific vaccine.
For example, anaphylaxis which occurs within four hours after a Gardasil vaccine administration may be considered a table injury. Vasovagal syncope which occurs within one hour after Gardasil administration or a type of shoulder injury called SIRVA which occurs within 48 hours may also be considered table injuries.
Determining whether you have a potential claim with the VICP can take a thorough review of your medical records. Furthermore, there is a time limit within which you are allowed to file a claim. Therefore, if you have been diagnosed with an injury or condition which may be related to a Gardasil vaccination, you should contact an attorney experienced with the VICP.